Jun Deng

892 total citations
30 papers, 597 citations indexed

About

Jun Deng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jun Deng has authored 30 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Jun Deng's work include Metabolism, Diabetes, and Cancer (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and RNA modifications and cancer (5 papers). Jun Deng is often cited by papers focused on Metabolism, Diabetes, and Cancer (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and RNA modifications and cancer (5 papers). Jun Deng collaborates with scholars based in China, Germany and Macao. Jun Deng's co-authors include Mei Peng, Sichun Zhou, Xiaoping Yang, Ting Tao, Caimei He, Yanjun Huang, Di Xiao, Qiongli Su, Kwame Oteng Darko and Zhiren Wang and has published in prestigious journals such as Molecules, Journal of Ethnopharmacology and Journal of Cellular Physiology.

In The Last Decade

Jun Deng

27 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Deng China 14 390 175 104 87 59 30 597
Ting Tao China 11 375 1.0× 140 0.8× 129 1.2× 86 1.0× 51 0.9× 15 609
Sichun Zhou China 13 382 1.0× 175 1.0× 96 0.9× 80 0.9× 62 1.1× 20 596
Sheng Huang China 14 385 1.0× 186 1.1× 82 0.8× 55 0.6× 62 1.1× 43 666
Mengmeng Dou China 15 322 0.8× 108 0.6× 70 0.7× 53 0.6× 97 1.6× 31 597
Kwame Oteng Darko China 8 325 0.8× 83 0.5× 84 0.8× 69 0.8× 33 0.6× 10 509
Yugen Chen China 12 358 0.9× 126 0.7× 73 0.7× 45 0.5× 44 0.7× 26 593
Xinxing Li China 15 264 0.7× 92 0.5× 141 1.4× 91 1.0× 46 0.8× 31 561
Veronica Cocetta Italy 13 317 0.8× 176 1.0× 98 0.9× 56 0.6× 67 1.1× 28 632
Jiao Li China 16 392 1.0× 132 0.8× 107 1.0× 71 0.8× 68 1.2× 31 686

Countries citing papers authored by Jun Deng

Since Specialization
Citations

This map shows the geographic impact of Jun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Deng more than expected).

Fields of papers citing papers by Jun Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Deng. The network helps show where Jun Deng may publish in the future.

Co-authorship network of co-authors of Jun Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Deng. A scholar is included among the top collaborators of Jun Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Deng. Jun Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xinrong, Man Ching Esther Chan, Berinderjeet Kaur, et al.. (2025). International comparative studies in mathematics education: a scoping review of the literature from 2014 to 2023. ZDM. 57(4). 745–761.
2.
Deng, Jun, Guanglei Qiao, Jing Yang, et al.. (2025). Gambogic acid induces ferroptosis and suppresses colorectal cancer progression by modulating the m6A modification of p62. Cellular Signalling. 135. 112024–112024.
4.
Yang, Xinrong, et al.. (2024). The relationship between opportunities to learn in teacher education and Chinese preservice teachers’ professional competence. Journal of Curriculum Studies. 58(1). 165–183. 1 indexed citations
5.
Chen, Tao, et al.. (2024). Integrated network pharmacology, metabolomics and molecular docking analysis to reveal the mechanisms of quercetin in the treatment of hyperlipidemia. Journal of Pharmaceutical and Biomedical Analysis. 252. 116507–116507. 6 indexed citations
6.
Xu, Lin, Lin‐wen Wu, Jun Deng, et al.. (2023). DSCC1 interacts with HSP90AB1 and promotes the progression of lung adenocarcinoma via regulating ER stress. Cancer Cell International. 23(1). 208–208. 9 indexed citations
7.
Zhang, Xingjian, Xin Hu, Xiangyi Chen, et al.. (2023). Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration. Molecules. 28(18). 6720–6720. 7 indexed citations
8.
Zhou, Sichun, Duo Li, Di Xiao, et al.. (2022). Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage. International Journal of Biological Sciences. 18(4). 1555–1568. 28 indexed citations
9.
Xiao, Di, Xin Hu, Mei Peng, et al.. (2022). Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy. Cell Death and Disease. 13(5). 499–499. 12 indexed citations
10.
Deng, Jun, Xü Lin, Qi Li, et al.. (2022). Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma. Cancer Cell International. 22(1). 189–189. 3 indexed citations
11.
Huang, Yanjun, Caimei He, Sichun Zhou, et al.. (2022). The beneficial effects of alpha‐tocopherol on intestinal function and the expression of tight junction proteins in differentiated segments of the intestine in piglets. Food Science & Nutrition. 11(2). 677–687. 4 indexed citations
12.
Zhou, Sichun, Mei Qin, Jing Tang, et al.. (2021). Phenformin and ataxia‐telangiectasia mutated inhibitors synergistically co‐suppress liver cancer cell growth by damaging mitochondria. FEBS Open Bio. 11(5). 1440–1451. 5 indexed citations
13.
Peng, Mei, Jun Deng, Sichun Zhou, et al.. (2019). Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth. Frontiers in Pharmacology. 10. 1159–1159. 19 indexed citations
14.
Peng, Mei, Jun Deng, Sichun Zhou, et al.. (2019). <p>The role of Clusterin in cancer metastasis</p>. Cancer Management and Research. Volume 11. 2405–2414. 39 indexed citations
15.
Xiao, Di, Zhicheng Lü, Zhiren Wang, et al.. (2019). Synthesis, biological evaluation and anti-proliferative mechanism of fluorine-containing proguanil derivatives. Bioorganic & Medicinal Chemistry. 28(2). 115258–115258. 9 indexed citations
16.
Deng, Jun, Mei Peng, Zhiren Wang, et al.. (2018). Novel application of metformin combined with targeted drugs on anticancer treatment. Cancer Science. 110(1). 23–30. 41 indexed citations
17.
Su, Qiongli, Ting Tao, Lei Tang, et al.. (2018). Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer. Journal of Cellular and Molecular Medicine. 22(5). 2774–2790. 27 indexed citations
18.
Tao, Ting, Qiongli Su, Jun Deng, et al.. (2018). Down‐regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP‐1c axis. Journal of Cellular Physiology. 234(3). 3088–3104. 68 indexed citations
20.
Deng, Jun, et al.. (2015). Lysimachia christinae Hance regresses preestablished cholesterol gallstone in mice. Journal of Ethnopharmacology. 166. 102–108. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026